Оментин-1 подкожной жировой ткани при ишемической болезни сердца
https://doi.org/10.25557/2073-7998.2020.11.21-30
Аннотация
Ключевые слова
Об авторах
И. А. ПобожеваРоссия
А. А. Пантелеева
Россия
Е. А. Полякова
Россия
К. В. Драчева
Россия
Н. Д. Разгильдина
Россия
О. В. Галкина
Россия
О. Д. Беляева
Россия
О. А. Беркович
Россия
Е. И. Баранова
Россия
С. Н. Пчелина
Россия
В. В. Мирошникова
Россия
Список литературы
1. Lau W.B., Ohashi K., Wang Y. et al. Role of Adipokines in Cardiovascular Disease. Circ J. 2017 Jun 23;81(7):920-928. doi: 10.1253/circj.CJ-17-0458.
2. Smékal A., Václavík J., Stejskal D. et al. Plasma levels and leucocyte RNA expression of adipokines in young patients with coronary artery disease, in metabolic syndrome and healthy controls. Cytokine. 2019 Oct; 122:154017. doi: 10.1016/j.cyto.2017.03.016.
3. Iwasaki K., Urabe N., Kitagawa A., Nagao T. The association of epicardial fat volume with coronary characteristics and clinical outcome. Int J Cardiovasc Imaging. 2018 Feb; 34(2):301-309. doi: 10.1007/s10554-017-1227-7.
4. Chistiakov D.A., Grechko A.V., Myasoedova V.A. et al. Impact of the cardiovascular system-associated adipose tissue on atherosclerotic pathology. Atherosclerosis. 2017 Aug; 263:361-368. doi: 10.1016/j.atherosclerosis.2017.06.017.
5. Shibata R., Ouchi N., Kikuchi R. et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis. 2011 Dec; 219(2):811-4. doi: 10.1016/j.atherosclerosis.2011.08.017.
6. Matsuzawa Y., Funahashi T., Nakamura T. The concept of metabolic syndrome: Contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb 2011; 18: 629 - 639. doi: 10.5551/jat.7922.
7. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85 - 97. doi: 10.1038/nri2921.
8. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015; 11(6):363-371. doi: 10.1038/nrendo.2015.58.
9. Watanabe T., Watanabe-Kominato K., Takahashi Y. et al. Adipose Tissue-Derived Omentin-1 Function and Regulation. Compr Physiol. 2017 Jun 18; 7(3):765-781. doi: 10.1002/cphy.c160043.
10. Mancuso P., Bouchard B. The Impact of Aging on Adipose Function and Adipokine Synthesis Front Endocrinol (Lausanne). 2019 Mar 11; 10: 137. doi: 10.3389/fendo.2019.00137.
11. Du Y., Ji Q., Cai L. et al. Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis. Cardiovasc Diabetol. 2016 Jun 28; 15:90. doi: 10.1186/s12933-016-0406-5.
12. Cătoi AF., Suciu Ş., Pârvu A.E. et al. Increased chemerin and decreased omentin-1 levels in morbidly obese patients are correlated with insulin resistance, oxidative stress and chronic inflammation. Clujul Med. 2014; 87(1):19-26. doi: 10.15386/cjm.2014.8872.871.afc1.
13. Onur I., Oz F., Yildiz S. et al. Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women. Angiology. 2014 Nov; 65(10):896-900. doi: 10.1177/0003319713511322.
14. de Souza Batista C.M., Yang R.-Z., Lee M.-J., et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007; 56(6):1655-1661. doi:10.2337/db06-1506.
15. Saely C.H., Leiherer A., Muendlein A., et al. High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis. Atherosclerosis. 2015; 244:38-43. doi: 10.1016/j.atherosclerosis.2015.10.100.
16. Kocijancic M., Cubranic Z., Vujicic B., et al. Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients. Int Urol Nephrol. 2016 Jul; 48(7):1145-54. doi: 10.1007/s11255-016-1275-2.
17. Mirzaei K., Hossein-Nezhad A., Keshavarz S.A. et al. Crosstalk between circulating peroxisome proliferator-activated receptor gamma, adipokines and metabolic syndrome in obese subjects. Diabetol Metab Syndr. 2013 Dec 12; 5(1):79. doi: 10.1186/1758-5996-5-79.
18. Grygiel-Górniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review. Nutr J. 2014 Feb 14; 13:17. doi: 10.1186/1475-2891-13-17.
19. Esteghamati A., Noshad S, Rabizadeh S. et al. Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial. Regul Pept. 2013 Mar 10; 182:1-6. doi: 10.1016/j.regpep.2012.12.005.
20. Greulich S., Chen W.J., Maxhera B. et al. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PLoS One. 2013;8(3):e59697. doi: 10.1371/journal.pone.0059697.
21. Бокерия Л.А., Аронов Д.М. Российские клинические рекомендации. Коронарное шунтирование больных ишемической болезнью сердца: реабилитация и вторичная профилактика. Кардио Соматика. 2016; 7(3-4):5-71.
22. Мирошникова В.В., Пантелеева А.А., Баженова Е.А. и др. Регуляция экспрессии генов транспортеров ABCA1 и ABCG1 в интраабдоминальной жировой ткани. Биомедицинская химия. 2016. 62(3): 283-289.
23. Shang F.J., Wang J.P., Liu X.T. et al. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers. 2011 Dec; 16(8):657-62. doi: 10.3109/1354750X.2011.622789.
24. Onat A., Ademoglu E., Karadeniz Y. et al. Population-based serum omentin-1 levels: paradoxical association with cardiometabolic disorders primarily in men. Biomark Med. 2018 Feb; 12(2):141-149. doi: 10.2217/bmm-2017-0197.
25. Harada K., Shibata R., Ouchi N. et al. Increased expression of the adipocytokine omentin in the epicardial adipose tissue of coronary artery disease patients. Atherosclerosis. 2016 Aug;251:299-304. doi: 10.1016/j.atherosclerosis.2016.07.003.
26. Moreno-Navarrete J.M., Catalán V., Ortega F. et al. Circulating omentin concentration increases after weight loss. Nutr Metab (Lond). 2010 Apr 9; 7:27. doi: 10.1186/1743-7075-7-27.
27. Jialal I., Devaraj S., Kaur H. et al. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013 Mar; 98(3):E514-7. doi: 10.1210/jc.2012-3673.
28. Urbanová M., Dostálová I., Trachta P. et al. Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus: the effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy. Physiol Res. 2014; 63(2):207-18.
29. Iacobellis G., Corradi D., Sharma A.M. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005 Oct; 2(10):536-43. doi: 10.1038/ncpcardio0319.
30. Vu A., Sidhom M.S., Bredbeck B.C. et al. Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease. Diabetol Metab Syndr. 2014 Jan 15; 6(1):4. doi: 10.1186/1758-5996-6-4.
31. Luque-Ramírez M., Martínez-García M.Á., Montes-Nieto R. et al. Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum Reprod. 2013 Jul; 28(7):1908-18. doi: 10.1093/humrep/det097.
32. Усенко Т.С., Мирошникова В.В., Баженова Е.А. и др. Экспрессия генов ITLN1, PPARγ и TNFα в интраабдоминальной жировой ткани. Цитология. 2017. 59(1): 27-33.
33. Park H.J., Park H.S., Lee J.U. et al. Gender-specific differences in PPARγ regulation of follicular helper T cell responses with estrogen. Sci Rep. 2016 Jun 23; 6:28495. doi: 10.1038/srep28495.
34. Dubois S.G., Heilbronn L.K., Smith S.R. et al. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity (Silver Spring). 2006 Sep; 14(9):1543-52. doi: 10.1038/oby.2006.178.
35. Motawi T.K., Shaker O.G., Ismail M.F., Sayed N.H. Peroxisome Proliferator-Activated Receptor Gamma in Obesity and Colorectal Cancer: the Role of Epigenetics. Sci Rep. 2017 Sep 6; 7(1):10714. doi: 10.1038/s41598-017-11180-6.
36. Takano H., Komuro I. Peroxisome Proliferator-Activated Receptor γ and Cardiovascular Diseases. Circulation Journal. 2009 73(2): 214-220. doi:10.1253/circj.cj-08-1071.
Рецензия
Для цитирования:
Побожева И.А., Пантелеева А.А., Полякова Е.А., Драчева К.В., Разгильдина Н.Д., Галкина О.В., Беляева О.Д., Беркович О.А., Баранова Е.И., Пчелина С.Н., Мирошникова В.В. Оментин-1 подкожной жировой ткани при ишемической болезни сердца. Медицинская генетика. 2020;19(11):21-30. https://doi.org/10.25557/2073-7998.2020.11.21-30
For citation:
Pobozheva I.A., Panteleeva A.A., Polyakova E.A., Dracheva K.V., Razgildina N.D., Galkina O.V., Belyaeva O.D., Berkovich O.A., Baranova E.I., Pchelina S.N., Miroshnikova V.V. Subcutaneous adipose tissue omentin-1 in coronary artery disease patients. Medical Genetics. 2020;19(11):21-30. (In Russ.) https://doi.org/10.25557/2073-7998.2020.11.21-30